Apatinib: get better application in gastric cancer and other cancers

Many thanks to Dr. Giandomenico Roviello, Giulia Borsella and Daniele Generali for that they have written the editorial (1) at Translational Cancer Research (TCR) invitation, e.g., “Expanding treatment options for metastatic gastric cancer”, discussing the clinical study (2) evaluating the efficacy and safety of apatinib vs. placebo in the treatment of patients with gastric- or gastro-esophageal junction adenocarcinoma for whom at least two lines of prior chemotherapy had failed. Their good suggestions and great expectation about apatinib further treatment and study on gastric cancer (GC) tremendously enlighten and inspired us.